REP-0003

N/A

Report date: 2025/12/31 13:42:32

Base Information

Drug NameREP-0003
Drug Alias NamemRNA encoding the cholesterol degrading platform (CDP) fusion proteinREP-0003
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHomozygous familial hypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRepair Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesRepair Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsHomozygous familial hypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A